Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-20-286884
Filing Date
2020-11-05
Accepted
2020-11-05 16:38:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D d30740dsc13d.htm SC 13D 81223
2 EX-99.1 d30740dex991.htm EX-99.1 25469
  Complete submission text file 0001193125-20-286884.txt   108335
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo Holdings A/S (Filed by) CIK: 0001388325 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto, Inc. (Subject) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91812 | Film No.: 201291100
SIC: 2834 Pharmaceutical Preparations